{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:35:05Z","timestamp":1786995305111,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ophtha.2017.12.038","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T07:55:03Z","timestamp":1518767703000},"page":"1088-1099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Dexamethasone Inserts in Noninfectious Uveitis"],"prefix":"10.1016","volume":"125","author":[{"given":"Dominika","family":"Pohlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit A.","family":"vom Brocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Winterhalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Thees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2017.12.038_bib1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"de Smet","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.ophtha.2017.12.038_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.038_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000336330","article-title":"Corticosteroid intravitreal implants","volume":"51","author":"De Smet","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.038_bib4","first-page":"1613","article-title":"Dexamethasone intravitreal implant for the treatment of noninfectious uveitis","volume":"5","author":"Hunter","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.038_bib5","doi-asserted-by":"crossref","first-page":"780634","DOI":"10.1155\/2013\/780634","article-title":"Drug delivery implants in the treatment of vitreous inflammation","volume":"2013","author":"Wang","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.ophtha.2017.12.038_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.12.038_bib7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Ozurdex Geneva Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.038_bib8","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.038_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/eye.2012.226","article-title":"Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion","volume":"27","author":"Moisseiev","year":"2013","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ophtha.2017.12.038_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3928\/23258160-20170130-10","article-title":"Efficacy of the intravitreal sustained-release dexamethasone implant for diabetic macular edema refractory to anti-vascular endothelial growth factor therapy: meta-analysis and clinical implications","volume":"48","author":"Khan","year":"2017","journal-title":"Opthalmic Surg Lasers Imaging Retina"},{"issue":"8","key":"10.1016\/j.ophtha.2017.12.038_bib11","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ophtha.2014.02.003","article-title":"Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis","volume":"121","author":"Tomkins-Netzer","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2017.12.038_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ajo.2014.09.003","article-title":"Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency","volume":"158","author":"Zarranz-Ventura","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.038_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT)","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2017.12.038_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.038_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bjo.2008.149039","article-title":"Intermediate uveitis: long-term course and visual outcome","volume":"93","author":"Vidovic-Valentincic","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2017.12.038_bib16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/IAE.0000000000000515","article-title":"Efficacy and safety of dexamethasone intravitreal implant for persistent uveitic cystoid macular edema","volume":"35","author":"Khurana","year":"2015","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ophtha.2017.12.038_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000362178","article-title":"Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema","volume":"232","author":"Habot-Wilner","year":"2014","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.ophtha.2017.12.038_bib18","first-page":"835","article-title":"Results of intravitreal dexamethasone implant 0.7 mg (Ozurdex\u00ae) in non-infectious posterior uveitis","volume":"8","author":"Yap","year":"2015","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2017.12.038_bib19","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ophtha.2014.04.012","article-title":"Dexamethasone intravitreal implant in the treatment of persistent uveitis macular edema in the absence of active inflammation","volume":"121","author":"Cao","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.12.038_bib20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ophtha.2006.03.027","article-title":"Impact of macular edema on visual acuity in uveitis","volume":"113","author":"Lardenoye","year":"2006","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.ophtha.2017.12.038_bib21","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1073\/pnas.1418316112","article-title":"Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A","volume":"112","author":"Schewitz-Bowers","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ophtha.2017.12.038_bib22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10050","key":"10.1016\/j.ophtha.2017.12.038_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a randomized, double-masked, randomized, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ophtha.2017.12.038_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/IAE.0b013e3182483348","article-title":"Long-term follow-up of inflammatory cystoid macular edema","volume":"32","author":"Tranos","year":"2012","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ophtha.2017.12.038_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bjo.85.3.261","article-title":"World blindness: a 21st century perspective","volume":"85","author":"Taylor","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2017.12.038_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/IAE.0b013e318297f842","article-title":"Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study)","volume":"34","author":"Capone","year":"2014","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ophtha.2017.12.038_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics","volume":"149","author":"Kempen","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2017.12.038_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.12.038_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for non-infectious posterior uveitis: thirty-four-week results of a multicentre randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2017.12.038_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2009.11.027","article-title":"Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in non-infectious posterior uveitis","volume":"117","author":"Pavesio","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2017.12.038_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2012.0180","article-title":"A\u00a0comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis","volume":"29","author":"Arcinue","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ophtha.2017.12.038_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","article-title":"Intraocular pressure monitoring post intravitreal steroids: a systematic review","volume":"58","author":"Kiddee","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.12.038_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12886-015-0148-2","article-title":"Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study","volume":"15","author":"Augustin","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2017.12.038_bib34","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/IAE.0000000000001369","article-title":"Safety of intravitreal dexamethasone implant (Ozurdex): the SAFODEX study. Incidence and risk factors of ocular hypertension","volume":"37","author":"Malcl\u00e8s","year":"2017","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ophtha.2017.12.038_bib35","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2017.12.038_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.12.038_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/09273948.2016.1184284","article-title":"Common and rare ocular side-effects of the dexamethasone implant","volume":"25","author":"Fassbender Adeniran","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2017.12.038_bib38","doi-asserted-by":"crossref","DOI":"10.1159\/000368987","article-title":"Fast and successful management of intraocular inflammation with a single intravitreal dexamethasone implant","author":"Pleyer","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2017.12.038_bib39","first-page":"1","article-title":"Intravitreal dexamethasone for the treatment of CMO associated with refractory sclerouveitis","author":"Pohlmann","year":"2016","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017315749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017315749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T17:44:24Z","timestamp":1530207864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642017315749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0161642017315749"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.038","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexamethasone Inserts in Noninfectious Uveitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}